Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1982 Mar 27;284(6320):917–918. doi: 10.1136/bmj.284.6320.917

Advances in respiratory distress syndrome.

N R Robertson
PMCID: PMC1496543  PMID: 6802346

Full text

PDF
917

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams F. H., Towers B., Osher A. B., Ikegami M., Fujiwara T., Nozaki M. Effects of tracheal instillation of natural surfactant in premature lambs. I. Clinical and autopsy findings. Pediatr Res. 1978 Aug;12(8):841–848. doi: 10.1203/00006450-197808000-00008. [DOI] [PubMed] [Google Scholar]
  2. Andersen G., Friis-Hansen B. Hypercholesterolemia in the newborn: occurrence after anterpartum treatment with betamethasone-phenobarbital-ritodrine for the prevention of the respiratory distress syndrome. Pediatrics. 1978 Jul;62(1):8–12. [PubMed] [Google Scholar]
  3. Ballard P. L., Ballard R. A., Granberg J. P., Sniderman S., Gluckman P. D., Kaplan S. L., Grumbach M. M. Fetal sex and prenatal betamethasone therapy. J Pediatr. 1980 Sep;97(3):451–454. doi: 10.1016/s0022-3476(80)80204-6. [DOI] [PubMed] [Google Scholar]
  4. Ballard R. A., Ballard P. L., Granberg J. P., Sniderman S. Prenatal administration of betamethasone for prevention of respiratory distress syndrome. J Pediatr. 1979 Jan;94(1):97–101. doi: 10.1016/s0022-3476(79)80368-6. [DOI] [PubMed] [Google Scholar]
  5. Bangham A. D., Morley C. J., Phillips M. C. The physical properties of an effective lung surfactant. Biochim Biophys Acta. 1979 Jun 21;573(3):552–556. doi: 10.1016/0005-2760(79)90229-7. [DOI] [PubMed] [Google Scholar]
  6. Chu J., Clements J. A., Cotton E. K., Klaus M. H., Sweet A. Y., Tooley W. H., Bradley B. L., Brandorff L. C. Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics. 1967 Oct;40(4 Suppl):709–782. [PubMed] [Google Scholar]
  7. Depp R., Boehm J. J., Nosek J. A., Dooley S. L., Hobart J. M. Antenatal corticosteroids to prevent neonatal respiratory distress syndrome: risk versus benefit considerations. Am J Obstet Gynecol. 1980 Jun 1;137(3):338–350. doi: 10.1016/0002-9378(80)90919-9. [DOI] [PubMed] [Google Scholar]
  8. Enhorning G., Hill D., Sherwood G., Cutz E., Robertson B., Bryan C. Improved ventilation of prematurely delivered primates following tracheal deposition of surfactant. Am J Obstet Gynecol. 1978 Nov 1;132(5):529–536. doi: 10.1016/0002-9378(78)90748-2. [DOI] [PubMed] [Google Scholar]
  9. Enhörning G., Grossman G., Robertson B. Tracheal deposition of surfactant before the first breath. Am Rev Respir Dis. 1973 Jun;107(6):921–927. doi: 10.1164/arrd.1973.107.6.921. [DOI] [PubMed] [Google Scholar]
  10. Enhörning G., Grossmann G., Robertson B. Pharyngeal deposition of surfactant in the premature rabbit fetus. Biol Neonate. 1973;22(1):126–132. doi: 10.1159/000240546. [DOI] [PubMed] [Google Scholar]
  11. Enhörning G., Robertson B. Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics. 1972 Jul;50(1):58–66. [PubMed] [Google Scholar]
  12. Fujiwara T., Maeta H., Chida S., Morita T., Watabe Y., Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet. 1980 Jan 12;1(8159):55–59. doi: 10.1016/s0140-6736(80)90489-4. [DOI] [PubMed] [Google Scholar]
  13. Hadjigeorgiou E., Kitsiou S., Psaroudakis A., Segos C., Nicolopoulos D., Kaskarelis D. Antepartum aminophylline treatment for prevention of the respiratory distress syndrome in premature infants. Am J Obstet Gynecol. 1979 Sep 15;135(2):257–260. doi: 10.1016/0002-9378(79)90355-7. [DOI] [PubMed] [Google Scholar]
  14. Hallman M., Feldman B. H., Kirkpatrick E., Gluck L. Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns. Pediatr Res. 1977 Jun;11(6):714–720. doi: 10.1203/00006450-197706000-00003. [DOI] [PubMed] [Google Scholar]
  15. Ikegami M., Jobe A., Glatz T. Surface activity following natural surfactant treatment in premature lambs. J Appl Physiol Respir Environ Exerc Physiol. 1981 Aug;51(2):306–312. doi: 10.1152/jappl.1981.51.2.306. [DOI] [PubMed] [Google Scholar]
  16. Ikegami M., Jobe A., Jacobs H., Jones S. J. Sequential treatments of premature lambs with an artificial surfactant and natural surfactant. J Clin Invest. 1981 Aug;68(2):491–496. doi: 10.1172/JCI110280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jacobs M. M., Knight A. B., Arias F. Maternal pulmonary edema resulting from betamimetic and glucocorticoid therapy. Obstet Gynecol. 1980 Jul;56(1):56–59. [PubMed] [Google Scholar]
  18. Kanjanapone V., Hartig-Beecken I., Epstein M. F. Effect of isoxsuprine on fetal lung surfactant in rabbits. Pediatr Res. 1980 Apr;14(4 Pt 1):278–281. doi: 10.1203/00006450-198004000-00003. [DOI] [PubMed] [Google Scholar]
  19. Liggins G. C., Howie R. N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972 Oct;50(4):515–525. [PubMed] [Google Scholar]
  20. Lorenz U., Rüttgers H., Fux G., Kubli F. Fetal pulmonary surfactant induction by bromhexine metabolite 8. Am J Obstet Gynecol. 1974 Aug 15;119(8):1126–1128. doi: 10.1016/0002-9378(74)90271-3. [DOI] [PubMed] [Google Scholar]
  21. Morley C. J., Bangham A. D., Miller N., Davis J. A. Dry artificial lung surfactant and its effect on very premature babies. Lancet. 1981 Jan 10;1(8211):64–68. doi: 10.1016/s0140-6736(81)90002-7. [DOI] [PubMed] [Google Scholar]
  22. Morley C. J., Banhham A. D., Johnson P., Thorburn G. D., Jenkin G. Physical and physiological properties of dry lung surfactant. Nature. 1978 Jan 12;271(5641):162–163. doi: 10.1038/271162a0. [DOI] [PubMed] [Google Scholar]
  23. Morley C., Robertson B., Lachmann B., Nilsson R., Bangham A., Grossmann G., Miller N. Artificial surfactant and natural surfactant. Comparative study of the effects on premature rabbit lungs. Arch Dis Child. 1980 Oct;55(10):758–765. doi: 10.1136/adc.55.10.758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Papageorgiou A. N., Desgranges M. F., Masson M., Colle E., Shatz R., Gelfand M. M. The antenatal use of betamethasone in the prevention of respiratory distress syndrome: a controlled double-blind study. Pediatrics. 1979 Jan;63(1):73–79. [PubMed] [Google Scholar]
  25. Robertson N. R., Tizard J. P. Prognosis for infants with idiopathic respiratory distress syndrome. Br Med J. 1975 Aug 2;3(5978):271–274. doi: 10.1136/bmj.3.5978.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Taeusch H. W., Jr, Frigoletto F., Kitzmiller J., Avery M. E., Hehre A., Fromm B., Lawson E., Neff R. K. Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics. 1979 Jan;63(1):64–72. [PubMed] [Google Scholar]
  27. Young B. K., Klein S. A., Katz M., Wilson S. J., Douglas G. W. Intravenous dexamethasone for prevention of neonatal respiratory distress: A prospective controlled study. Am J Obstet Gynecol. 1980 Sep 15;138(2):203–209. doi: 10.1016/0002-9378(80)90036-8. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES